OBJECTIVES: To estimate the frequency and evolution of heart involvement in human African trypanosomiasis (HAT) using electrocardiogram (ECG) findings; to describe these findings and to assess the frequency and clinical relevance of symptoms and signs before and after treatment. METHODS: In a prospective cohort study ECG findings, signs and symptoms consistent with heart failure and cardiac laboratory parameters were studied at baseline, 2 days after the end of treatment and 3 months later. RESULTS: Major ECG alterations were significantly more frequent in HAT patients than in healthy controls (71%vs. 18%; P < 0.001); 31% were low voltage changes, 34% were repolarization changes. ECG signs of necrosis and conduction problems were rare. Symptoms consistent with heart failure such as exertional dyspnoea (19%vs. 1.7%; P = 0.002) or palpitations (18%vs. 5%; P = 0.28) occurred more frequently in patients than in controls. The median NT-proBNP was significantly higher in HAT patients than in controls (85.2 vs. 28 pg/ml; P < 0.001). Troponin levels were normal. At the end of treatment repolarization changes appeared or worsened in 33.4%. Such changes improved or disappeared at follow-up in 33.1% of the patients. CONCLUSIONS: Cardiac involvement documented by ECG alterations is common in HAT patients, but cardiopathy rarely causes severe congestive heart failure and subsides after treatment. ECG alterations immediately after treatment and their improvement 3 months later may be the result of a treatment-induced inflammatory reaction.
OBJECTIVES: To estimate the frequency and evolution of heart involvement in human African trypanosomiasis (HAT) using electrocardiogram (ECG) findings; to describe these findings and to assess the frequency and clinical relevance of symptoms and signs before and after treatment. METHODS: In a prospective cohort study ECG findings, signs and symptoms consistent with heart failure and cardiac laboratory parameters were studied at baseline, 2 days after the end of treatment and 3 months later. RESULTS: Major ECG alterations were significantly more frequent in HAT patients than in healthy controls (71%vs. 18%; P < 0.001); 31% were low voltage changes, 34% were repolarization changes. ECG signs of necrosis and conduction problems were rare. Symptoms consistent with heart failure such as exertional dyspnoea (19%vs. 1.7%; P = 0.002) or palpitations (18%vs. 5%; P = 0.28) occurred more frequently in patients than in controls. The median NT-proBNP was significantly higher in HAT patients than in controls (85.2 vs. 28 pg/ml; P < 0.001). Troponin levels were normal. At the end of treatment repolarization changes appeared or worsened in 33.4%. Such changes improved or disappeared at follow-up in 33.1% of the patients. CONCLUSIONS: Cardiac involvement documented by ECG alterations is common in HAT patients, but cardiopathy rarely causes severe congestive heart failure and subsides after treatment. ECG alterations immediately after treatment and their improvement 3 months later may be the result of a treatment-induced inflammatory reaction.
Authors: Alicia Hidron; Nicholas Vogenthaler; José I Santos-Preciado; Alfonso J Rodriguez-Morales; Carlos Franco-Paredes; Anis Rassi Journal: Clin Microbiol Rev Date: 2010-04 Impact factor: 26.132
Authors: Robert H Barker; Hanlan Liu; Bradford Hirth; Cassandra A Celatka; Richard Fitzpatrick; Yibin Xiang; Erin K Willert; Margaret A Phillips; Marcel Kaiser; Cyrus J Bacchi; Aixa Rodriguez; Nigel Yarlett; Jeffrey D Klinger; Edmund Sybertz Journal: Antimicrob Agents Chemother Date: 2009-03-16 Impact factor: 5.191
Authors: Charlotte S McCarroll; Charlotte L Rossor; Linda R Morrison; Liam J Morrison; Christopher M Loughrey Journal: PLoS Negl Trop Dis Date: 2015-05-29
Authors: Charles D Kato; Ann Nanteza; Claire Mugasa; Andrew Edyelu; Enock Matovu; Vincent P Alibu Journal: PLoS One Date: 2015-02-26 Impact factor: 3.240
Authors: Johannes A Blum; Caecilia Schmid; Christian Burri; Christoph Hatz; Carol Olson; Blaise Fungula; Leon Kazumba; Patrick Mangoni; Florent Mbo; Kambau Deo; Alain Mpanya; Amadeo Dala; Jose R Franco; Gabriele Pohlig; Michael J Zellweger Journal: PLoS Negl Trop Dis Date: 2009-02-17
Authors: Elspeth B Elliott; Douglas McCarroll; Hisashi Hasumi; Claire E Welsh; Amanda A Panissidi; Nathaniel G Jones; Charlotte L Rossor; Andy Tait; Godfrey L Smith; Jeremy C Mottram; Liam J Morrison; Christopher M Loughrey Journal: Cardiovasc Res Date: 2013-07-26 Impact factor: 10.787